CSSi LifeSciences™ Executives Featured at Colorado BioScience Association BioBoot Camp 2017
Approximately 40 leading life science industry influencers participated in two-day Denver-based program, April 20-21, 2017
GLEN BURNIE, Md., April 21, 2017 /PRNewswire/ -- Today, Friday, April 21, 2017, members of CSSi LifeSciences™'s executive team served as featured speakers for BioBoot Camp 2017, a signature program produced by the Colorado BioScience Association (CBSA). Jim Sergi, President of CSSi LifeSciences, and Heidi Nelson-Keherly, Ph.D., Executive Director of Preclinical Research at CSSi LifeSciences, provided real-world insights on successfully transitioning innovations into the marketplace to 30 life science start-ups from all across the state of Colorado.
"CSSi LifeSciences was honored to participate in CBSA's BioBoot Camp," said Sergi. "It was an incredible experience to be a part of such an effort in which some of Colorado and the industry's leading life science experts gathered together to support CBSA and its mission as well as promote the growth of the industry within the state."
Dr. Nelson-Keherly's presentation "Preclinical Drug Discovery and Development" outlined the major steps required for commercializing a drug, including details from the discovery phase as well as the manufacturing and safety studies needed for the Investigational New Drug (IND) filing. She also covered the steps needed to prepare and submit the IND application to the Food and Drug Administration prior to first-in-man studies. Shortly after Dr. Nelson-Keherly spoke, Sergi gave a talk titled, "SmartStart™ your Clinical Drug Development," where he discussed the major clinical and regulatory processes required for commercializing a drug or biologic for a New Drug Application or Biologic License Application filing. He also spoke about the strategic considerations needed to accelerate one's clinical program, while mitigating risk and driving value.
"BioBoot Camp continues to be one of the most important programs offered by the Colorado BioScience Association," said April Giles, President & CEO of the Colorado BioScience Association. "Along with our partners at Dorsey and Whitney, we provide relevant business and clinical content to help bioscience start-ups address the necessary fundamentals to transform their technology into a viable company. Information provided by experts such as Dr. Nelson-Keherly and Jim Sergi is a critical part of this endeavor."
For more than 10 years, BioBoot Camp has provided individuals with the necessary tools and resources to meet their key development and commercialization goals. Attendee companies representing biotech, pharma, medical device, ag-bio, diagnostic and digital health sectors learn valuable information from experienced entrepreneurs about the trends, opportunities and challenges of transforming technologies into a viable and successful business venture, while trying to avoid legal, financial and regulated pitfalls that may be encountered along the way.
About CSSi LifeSciences:
CSSi LifeSciences ensures a successful and expeditious pathway to commercialization for our clients' drugs and medical devices by providing insight-driven analysis that saves time, development costs and resources. CSSi LifeSciences enables faster, more informed decision making to increase commercial success, while reducing the risk of late-stage failures and post-authorization action. CSSi LifeSciences is headquartered in Baltimore, MD, with additional offices in San Francisco, CA, London, UK and Hyderabad, India. For more information, please visit: www.cssilifesciences.com, email: [email protected] or call: +1(888) 279-8388.
About Colorado BioScience Association:
Colorado BioScience Association champions life science. We serve as the hub of Colorado's thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.
Media Contacts:
Courtney Megaughey
Public Relations & Marketing Coordinator
CSSi LifeSciences
(443) 308-5831
[email protected]
Tom Borak
Communications and Membership Manager
Colorado BioScience Association
(720) 382-5918
[email protected]
SOURCE CSSi LifeSciences
Share this article